Effect of COV2 vaccine formulation on the ability to generate antibodies against coronavirus

Category Primary study
Registry of TrialsClinical Trials Information System
Year 2025
This article has no abstract
Epistemonikos ID: 2c4fff4609e4f38780ea0307183303c08fc1f709
First added on: Jan 17, 2026